{
    "2019-08-16": [
        [
            {
                "time": "2019-08-27",
                "original_text": "科創板上市委：華熙生物、博瑞醫藥首發事項定於8月27日上會",
                "features": {
                    "keywords": [
                        "科創板",
                        "華熙生物",
                        "博瑞醫藥",
                        "首發",
                        "上會"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "醫療健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-27",
                "original_text": "科創板上市委：定於8月27日審議華熙生物、博瑞生物首發申請",
                "features": {
                    "keywords": [
                        "科創板",
                        "華熙生物",
                        "博瑞生物",
                        "首發",
                        "審議"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "醫療健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-27",
                "original_text": "每經小強快訊：華熙生物科技股份有限公司和華泰聯合證券有限責任公司關於審核中心意見落實函的回復",
                "features": {
                    "keywords": [
                        "華熙生物",
                        "華泰聯合證券",
                        "審核中心意見",
                        "落實函",
                        "回復"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-27",
                "original_text": "科創板擬上市企業博瑞醫藥、華熙生物披露上會稿",
                "features": {
                    "keywords": [
                        "科創板",
                        "博瑞醫藥",
                        "華熙生物",
                        "上會稿",
                        "披露"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "醫療健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}